Cargando…

Enhancing therapeutic vaccination by blocking PD-1–mediated inhibitory signals during chronic infection

Therapeutic vaccination is a potentially promising strategy to enhance T cell immunity and viral control in chronically infected individuals. However, therapeutic vaccination approaches have fallen short of expectations, and effective boosting of antiviral T cell responses has not always been observ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ha, Sang-Jun, Mueller, Scott N., Wherry, E. John, Barber, Daniel L., Aubert, Rachael D., Sharpe, Arlene H., Freeman, Gordon J., Ahmed, Rafi
Formato:	Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 2008
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2275378/ https://www.ncbi.nlm.nih.gov/pubmed/18332181 http://dx.doi.org/10.1084/jem.20071949

Ejemplares similares

Reinvigorating exhausted HIV-specific T cells via PD-1–PD-1 ligand blockade
por: Freeman, Gordon J., et al.
Publicado: (2006)

Genetic absence of PD-1 promotes accumulation of terminally differentiated exhausted CD8(+) T cells
por: Odorizzi, Pamela M., et al.
Publicado: (2015)

Interplay between regulatory T cells and PD-1 in modulating T cell exhaustion and viral control during chronic LCMV infection
por: Penaloza-MacMaster, Pablo, et al.
Publicado: (2014)

PD-L1 regulates the development, maintenance, and function of induced regulatory T cells
por: Francisco, Loise M., et al.
Publicado: (2009)

RGMb is a novel binding partner for PD-L2 and its engagement with PD-L2 promotes respiratory tolerance
por: Xiao, Yanping, et al.
Publicado: (2014)

Tissue expression of PD-L1 mediates peripheral T cell tolerance
por: Keir, Mary E., et al.
Publicado: (2006)

PD-L1 on tumor cells is sufficient for immune evasion in immunogenic tumors and inhibits CD8 T cell cytotoxicity
por: Juneja, Vikram R., et al.
Publicado: (2017)

Monitoring PD-1 Phosphorylation to Evaluate PD-1 Signaling during Antitumor Immune Responses
por: Bu, Xia, et al.
Publicado: (2021)

PD-1 blockade following ART interruption enhances control of pathogenic SIV in rhesus macaques
por: Velu, Vijayakumar, et al.
Publicado: (2022)

Inclusion of CD80 in HSV Targets the Recombinant Virus to PD-L1 on DCs and Allows Productive Infection and Robust Immune Responses
por: Mott, Kevin R., et al.
Publicado: (2014)

Therapeutic PD-L1 antibodies are more effective than PD-1 antibodies in blocking PD-1/PD-L1 signaling
por: De Sousa Linhares, Annika, et al.
Publicado: (2019)

Role of PD-1 co-inhibitory pathway in HIV infection and potential therapeutic options
por: Velu, Vijayakumar, et al.
Publicado: (2015)

CD4 T Cell-Derived IFN-γ Plays a Minimal Role in Control of Pulmonary Mycobacterium tuberculosis Infection and Must Be Actively Repressed by PD-1 to Prevent Lethal Disease
por: Sakai, Shunsuke, et al.
Publicado: (2016)

Enhancing SIV-Specific Immunity In Vivo by PD-1 Blockade
por: Velu, Vijayakumar, et al.
Publicado: (2008)

Coregulation of CD8(+) T cell exhaustion during chronic viral infection by multiple inhibitory receptors
por: Blackburn, Shawn D., et al.
Publicado: (2008)

Unblock the Block! Preventing Inhibitory Failure to Maintain Inhibitory Restraint
por: Lignani, Gabriele
Publicado: (2022)

PD-1 restraint of regulatory T cell suppressive activity is critical for immune tolerance
por: Tan, Catherine L., et al.
Publicado: (2020)

Structural basis for blocking PD-1-mediated immune suppression by therapeutic antibody pembrolizumab
por: Na, Zhenkun, et al.
Publicado: (2017)

Synergistic Reversal of Intrahepatic HCV-Specific CD8 T Cell Exhaustion by Combined PD-1/CTLA-4 Blockade
por: Nakamoto, Nobuhiro, et al.
Publicado: (2009)

The PD-1/PD-L1 Inhibitory Pathway is Altered in Primary Glomerulonephritides
por: Grywalska, Ewelina, et al.
Publicado: (2017)

PD-1 pathway regulates ILC2 metabolism and PD-1 agonist treatment ameliorates airway hyperreactivity
por: Helou, Doumet Georges, et al.
Publicado: (2020)

A Comparison of Murine PD-1 and PD-L1 Monoclonal Antibodies
por: Bu, Melissa T., et al.
Publicado: (2022)

mTOR regulates T cell exhaustion and PD-1–targeted immunotherapy response during chronic viral infection
por: Ando, Satomi, et al.
Publicado: (2023)

Oncolytic measles vaccines encoding PD-1 and PD-L1 checkpoint blocking antibodies to increase tumor-specific T cell memory
por: Veinalde, Rūta, et al.
Publicado: (2021)

PD-1 regulates germinal center B cell survival and the formation and affinity of long-lived plasma cells
por: Good-Jacobson, Kim L., et al.
Publicado: (2010)

PD-L2 controls peripherally induced regulatory T cells by maintaining metabolic activity and Foxp3 stability
por: Hurrell, Benjamin P., et al.
Publicado: (2022)

PD-L1/PD-1: new kid on the “immune metabolic” block
por: Qorraj, Mirjeta, et al.
Publicado: (2017)

The PD-L1/PD-1 Axis Blocks Neutrophil Cytotoxicity in Cancer
por: Yajuk, Olga, et al.
Publicado: (2021)

CTLA-4 Synergizes With PD1/PD-L1 in the Inhibitory Tumor Microenvironment of Intrahepatic Cholangiocarcinoma
por: Guo, Xiao-Jun, et al.
Publicado: (2021)

A novel approach to identifying patterns of human invasion-inhibitory antibodies guides the design of malaria vaccines incorporating polymorphic antigens
por: Drew, Damien R., et al.
Publicado: (2016)

Phosphorylation of PD-1-Y248 is a marker of PD-1-mediated inhibitory function in human T cells
por: Bardhan, Kankana, et al.
Publicado: (2019)

Blocking the PD-1/PD-L1 axis in dendritic cell-stimulated Cytokine-Induced Killer Cells with pembrolizumab enhances their therapeutic effects against hepatocellular carcinoma
por: Zhang, Wan, et al.
Publicado: (2019)

Rational development of molecularly imprinted nanoparticles for blocking PD-1/PD-L1 axis
por: Gu, Zikuan, et al.
Publicado: (2022)

PD-1(+) mast cell enhanced by PD-1 blocking therapy associated with resistance to immunotherapy
por: Li, Jun, et al.
Publicado: (2022)

Lack of PD-L1 Expression by iNKT Cells Improves the Course of Influenza A Infection
por: Maazi, Hadi, et al.
Publicado: (2013)

Interleukin 15 Is Required for Proliferative Renewal of Virus-specific Memory CD8 T Cells
por: Becker, Todd C., et al.
Publicado: (2002)

Antiviral Vaccines: Challenges and Advances
por: Ellebedy, Ali H., et al.
Publicado: (2016)

Mechanistic dissection of the PD-L1:B7-1 co-inhibitory immune complex
por: Garrett-Thomson, Sarah C., et al.
Publicado: (2020)

Rationale for an Association Between PD1 Checkpoint Inhibition and Therapeutic Vaccination Against HIV
por: Filaci, Gilberto, et al.
Publicado: (2018)

Involvement of the PD-1/PD-L1 Co-Inhibitory Pathway in the Pathogenesis of the Inflammatory Stage of Early-Onset Preeclampsia
por: Meggyes, Matyas, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_qc5thu20fikiqrgafr2egrjob1